|
![]() |
GanciclovirThis page contains recent news articles, when available, and an overview of Ganciclovir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ganciclovir (when available) Ganciclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against herpes simplex virus types 1 (HSV-1), Ganciclovir is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts Ganciclovir into Ganciclovir monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. in vitro, Ganciclovir triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, Ganciclovir triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where Ganciclovir triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand. For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Mechanism Of Action: Ganciclovir stops replication of herpes viral DNA in 3 ways: 1) competitive inhibition of viral DNA polymerase, 2) incorporation into and termination of the growing viral DNA chain, and 3) inactivation of the viral DNA polymerase. Ganciclovir targets HSV and VSV thymidine kinase News Articles on Ganciclovir Questions And Answers On the Recommendation for the Refusal of the Marketing ... - Dec 18, 2009 Cerepro was to be used in combination with a medicine called ganciclovir sodium to treat high-grade glioma in patients who are eligible for surgery. ... PharmaLive.com (press release) EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dec 18, 2009 ...adenoviral vector-mediated Herpes Simplex Virus-thymidine kinase gene used with subsequent administration of ganciclovir), from Ark Therapeutics Ltd, ... Wall Street Journal A novel Bifidobacterium infantis -mediated TK/GCV suicide gene therapy system ... - Dec 16, 2009 The engineered BI-TK was injected into tumor-bearing rats via tail vein, followed by intraperitoneal injection of ganciclovir (GCV). ... 7thSpace Interactive (press release) European Medicines Agency recommendation on Cerepro - Dec 19, 2009 In the following days, ganciclovir, is given intravenously. Once treated, healthy brain cells surrounding the site where the tumour was removed express the ... PipelineReview.com (press release) CBG: positief advies voor DuoCover, negatief advies voor Cerepro - Dec 24, 2009 ...toediening van ganciclovir) is een geneesmiddel voor gentherapie, geïndiceerd voor de behandeling van hooggradig glioom (een bepaald type hersentumor). ... Medical facts In latest bigoted smear, Fox leads right-wing media assault on Jennings ... - Oct 23, 2009 In the last year, Act-Up members say, their pressure has played a significant role in making available faster than usual two new drugs -- ganciclovir and ... Media Matters for America … in Neonates Following Intravenous Administration of Ganciclovir... - Nov 7, 2006 Cytomegalovirus (CMV) is the most common viral congenital infection, producing both sensorineural hearing loss and mental retardation. ... Nature.com Learn about Ganciclovir from Consumer Reports Health. - Jan 4, 2005 Ganciclovir may lower the number of all types of cells in your blood, causing serious and ... Full Alert. Ganciclovir capsules are used to treat ... consumerreports.org Effectiveness of ganciclovir against human herpesvirus-6 excreted in ... - Mar 5, 2007 Correspondence: Dr P Ljungman, Hematology Center, Karolinska University Hospital, Stockholm SE-14186, Sweden. E-mail: Per.Ljungman@ki.se ... Nature.com Preemptive therapy with ganciclovir 5 mg/kg once daily for … - Nov 5, 2007 Correspondence: Dr A Tomonari, Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, ... Nature.com Intravitreal ganciclovir injections in aqueous cytomegalovirus DNA … - Sep 30, 2005 Teoh et al 1 suggested that Posner–Schlossman Syndrome (PSS) may represent a spectrum of anterior chamber inflammatory responses to local viral reactivation ... Nature.com Learn about Ganciclovir Injection from Consumer Reports Health. - Jan 8, 2006 Ganciclovir may lower the number of all types of cells in your blood, causing serious and ... Full Alert. Your doctor has ordered ganciclovir, an antiviral ... consumerreports.org Ganciclovir (Systemic).(Drug overview) - May 1, 2006 Ganciclovir (gan-SYE-kloe-vir) is an antiviral. It is used to treat infections caused by viruses. Ganciclovir is used to treat the symptoms of ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com GANCICLOVIR (Oral route, Intravenous route) - gan-SYE-kloe-veer.(Drug... - May 1, 2007 The clinical toxicity of ganciclovir and ganciclovir sodium for injection includes granulocytopenia, anemia, and thrombocytopenia. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Ganciclovir Side Effects from Consumer Reports Health. - Jan 4, 2005 Ganciclovir may lower the number of all types of cells in your blood, causing serious and ... Full Alert. Ganciclovir may lower the number of all types of ... consumerreports.org Valganciclovir Versus IV Ganciclovir - Sep 12, 2007 The long-anticipated VICTOR study (reported in this issue of American Journal of Transplantation) represents the first large, randomized, multicenter trial ... Medscape Ganciclovir (Implantation-Ophthalmic).(Drug overview) - Aug 1, 2006 Ganciclovir ( gan-SYE-kloe-veer) is an antiviral medicine that is used in an implant that is inserted into the eye during surgery. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Ganciclovir (Implantation-Ophthalmic). - Oct 27, 2005 Ganciclovir ( gan-SYE-kloe-veer) is an antiviral medicine that is used in an implant that is inserted into the eye during surgery. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Sirion obtains US rights to topical ganciclovir gel for viral eye... - Jan 23, 2007 TAMPA, Fla. — Sirion Therapeutics has obtained exclusive US rights to develop and market a topical ganciclovir gel as a treatment for herpes simplex ... OSN SuperSite Stem cells in the hair follicle bulge contribute to wound repair but... - Nov 20, 2005 ...(a–d) Krt1-15–HSV-TK ROSA26 grafts (outlined by broken line) after start of ganciclovir administration (from days 1 to 5). Hair loss occurred rapidly. ... Nature.com … : Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the... - Nov 3, 2008 Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be ... Pay-Per-View - PR Newswire - HighBeam Research Taking Ganciclovir Injection from Consumer Reports Health. - Jan 8, 2006 Ganciclovir may lower the number of all types of cells in your blood, causing serious and ... Full Alert. Ganciclovir may cause side effects. ... consumerreports.org Tampa ophthalmic company looks to France for eye product - Jan 17, 2007 The company hopes to file a new drug application for ganciclovir ophthalmic gel with the US Food and Drug Administration by the end of calendar year 2007. ... Bizjournals.com … -Related Infection; Preemptive ganciclovir for CMV disease post... - Apr 11, 2005 ..."Preemptive ganciclovir treatment was started when more than 5 CMV ... A strategy of ganciclovir treatment focusing on patients at higher risk could reduce ... Pay-Per-View - Stem Cell Week - Factiva, from Dow Jones Options for treating ganciclovir-resistant CMV discussed at IDSA … - Oct 16, 2006 Cytomegalovirus (CMV) is an AIDS-defining condition and treatment options have changed little in recent years. This is of significant concern as CMV can ... Aidsmap … -Related Infection; Preemptive ganciclovir for CMV disease post... - Apr 13, 2005 ..."Preemptive ganciclovir treatment was started when more than 5 CMV ... A strategy of ganciclovir treatment focusing on patients at higher risk could reduce ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones GANCICLOVIR (Intraocular route) - gan-SYE-kloe-veer.(Drug overview) - May 1, 2007 Ganciclovir is an antiviral medicine that is used in an implant that is inserted into the eye during surgery. The ganciclovir implant is used to treat a ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Mayo Clinic expertise - Mar 15, 2008 There's no specific treatment for roseola, although some doctors may prescribe the antiviral medication ganciclovir (Cytovene) to treat the infection in ... MayoClinic.com New Treatment Guidelines Recommend VALCYTE(R) for AIDS-Related … - Jan 31, 2005 The guidelines also state that the ganciclovir intraocular implant plus VALCYTE is ... VALCYTE works by enhancing the absorption of ganciclovir through the ... RedOrbit Valcyte as effective as ganciclovir in CMV.(cytomegalovirus)(Brief... - May 14, 2007 Swiss drug major Roche says that the results of a trial of its oral antiviral Valcyte (valganciclovir), designed to treat cytomegalovirus infection in ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Cancer Gene Therapy; HSV-tk plus ganciclovir gene therapy displays … - Jun 7, 2006 2006 JUN 7 - (NewsRx.com) -- According to recently published research from the United States, HSV-tk plus ganciclovir gene therapy displays prostate tumor ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Transplant Medicine; Ganciclovir delays cytomegalovirus infection in ... - Mar 28, 2005 2005 MAR 28 - (NewsRx.com) -- Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Utility of oral valganciclovir for the treatment of cytomegalovirus... - Aug 23, 2007 ...(2007) Oral valganciclovir is noninferior to intravenous ganciclovir for the ... To compare the efficacy and safety of intravenous ganciclovir with that of ... Nature.com Transplant Medicine; Ganciclovir delays cytomegalovirus infection in ... - Apr 2, 2005 2005 APR 2 - (NewsRx.com) -- Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Oral valganciclovir as pre-emptive therapy has similar efficacy on … - Feb 27, 2006 In conclusion, pre-emptive treatment with valganciclovir and ganciclovir, ... 7, 8 The major drawback limiting the use of oral ganciclovir is its poor ... Nature.com Transplant Medicine; Ganciclovir delays cytomegalovirus infection in ... - Mar 29, 2005 2005 MAR 29 - (NewsRx.com) -- Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. ... Pay-Per-View - Virus Weekly - Factiva, from Dow Jones Sirion Therapeutics Receives Orphan Drug Designation For Ophthalmic … - Apr 17, 2007 ..."Topical ganciclovir has been available in Europe for the treatment of ocular viral infections for over 10 years. This product has the potential to advance ... Medical News Today - Medical News Today (press release) Antiviral prophylaxis for the prevention of post-transplantation … - Jan 27, 2006 ...(2005) Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative ... For every 30 days of treatment, ganciclovir, but not aciclovir, ... Nature.com Figure 6 : Endogenous microRNA can be broadly exploited to regulate … - Nov 16, 2007 Ganciclovir was added to a final concentration of 0.5 g/ml for 3 d. ... TK.302aT (GFP) transduced cells, untreated and 1 week after ganciclovir. ... Nature.com … -Related Infection; Preemptive ganciclovir for CMV disease post... - Apr 16, 2005 ..."Preemptive ganciclovir treatment was started when more than 5 CMV ... A strategy of ganciclovir treatment focusing on patients at higher risk could reduce ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … ; HIV-1 TAT protein transduction domain constructs enhance ganciclov... - Aug 18, 2005 ..."To study the spreading of TAT fusion proteins and their potency to enhance thymidine kinase/ ganciclovir (HSV-TK/GCV) cancer gene therapy, we constructed a ... Pay-Per-View - Gene Therapy Weekly - Factiva, from Dow Jones … Gene Therapy; FHPG radiotracer uptake does not resemble ganciclovir... - Feb 21, 2005 2005 FEB 21 - (NewsRx.com & NewsRx.net) -- FHPG radiotracer uptake does not resemble ganciclovir uptake. According to published research from the ... Pay-Per-View - Cancer Gene Therapy Week - Factiva, from Dow Jones HIV/AIDS; Studies from Italy, France and the United States describe... - May 17, 2006 Study 1: Ganciclovir is associated with low or undetectable Epstein-Barr ... The objective of this study was to assess the effect of ganciclovir on EBV DNA ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … Gene Therapy; FHPG radiotracer uptake does not resemble ganciclovir... - Feb 24, 2005 2005 FEB 24 - (NewsRx.com & NewsRx.net) -- FHPG radiotracer uptake does not resemble ganciclovir uptake. According to published research from the ... Pay-Per-View - Gene Therapy Weekly - Factiva, from Dow Jones … Gene Therapy; FHPG radiotracer uptake does not resemble ganciclovir... - Feb 22, 2005 2005 FEB 22 - (NewsRx.com & NewsRx.net) -- FHPG radiotracer uptake does not resemble ganciclovir uptake. According to published research from the ... Pay-Per-View - Science Letter - Factiva, from Dow Jones ë¯¸êµ ìˆ˜ìž…ì•½ 30종 모ë‘? 금수-미êµë‚´ ìƒ?ì‚° ì?˜ì•½í’ˆë§Œ ì œì™¸ - Sep 18, 2008 ...오ì§? 란박시 ì œì•½íšŒì‚¬ë§Œì?´ ë¯¸êµ ë‚´ì—? ì—?ì?´ì¦ˆ 환ìž?ì—?게 í?”한 ë°”ì?´ëŸ¬ìФ 안질환 ê°?ì—¼ 치료ì—? 사용ë?˜ëŠ” ì?˜ì•½í’ˆì?¸ ganciclovir 캅셀ì?„ ë?…ì ? ê³µê¸‰í•˜ê³ ìžˆì—ˆë‹¤ê³ ë°?혔다. ... 메디í?¬ë‰´ìФ Transplantation, May 2005 - Jun 28, 2005 Initially, patients were randomized 1:1:1 to 3 months of therapy with either oral ganciclovir (1 g 3 times daily), valacyclovir (2 g 4 times daily), ... Medscape Delayed Antiviral Regimen Effective for Preventing Posttransplant... - Jul 25, 2006 All patients received intravenous ganciclovir or oral valganciclovir for 2 weeks, ... "The oral agent was substituted for IV ganciclovir after it became ... DG News Filgrastim and alemtuzumab (Campath-1H) for refractory chronic … - Apr 28, 2005 The patient with CMV pneumonia died; ganciclovir cleared CMV in the other ... Despite treatment with CMV immune globulin, ganciclovir and foscarnet, ... Nature.com Pediatric standard-risk AML with fully matched sibling donors: to … - Jun 30, 2008 Ganciclovir prophylaxis to prevent cytomegalovirus disease after ... Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ... Nature.com Study explores corticosteroid implant treatment for uveitis: NEI... - Nov 1, 2007 He said a study comparing the intravitreal ganciclovir implant (Vitrasert, Bausch & Lomb) with systemic ganciclovir therapy for AIDS-related cytomegalovirus ... Free with registration - Ophthalmology Times - AccessMyLibrary.com Leiden University, Netherlands; New Leiden University, Netherlands, … - Jan 2, 2007 Study 2: Oral valganciclovir is similar in efficacy to intravenous ganciclovir for pre-emptive treatment of cytomegalovirus in allogeneic stem cell ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Ranbaxy Shaken By FDA Action - Sep 17, 2008 One product, Ganciclovir Sodium, is not on the confiscation list because it is ... Ganciclovir Sodium is the active ingredient in an antiviral medication ... Forbes Cytomegalovirus; Treatment for AIDS-related cytomegalovirus receives ... - Mar 1, 2005 The guidelines also state that the ganciclovir intraocular implant plus VALCYTE is ... VALCYTE works by enhancing the absorption of ganciclovir through the ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Cytomegalovirus; Treatment for AIDS-related cytomegalovirus receives ... - Mar 2, 2005 The guidelines also state that the ganciclovir intraocular implant plus VALCYTE is ... VALCYTE works by enhancing the absorption of ganciclovir through the ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones Cytomegalovirus; Treatment for AIDS-related cytomegalovirus receives ... - Mar 5, 2005 The guidelines also state that the ganciclovir intraocular implant plus VALCYTE is ... VALCYTE works by enhancing the absorption of ganciclovir through the ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Press Release: New Treatment Guidelines Recommend VALCYTE(R) for … - Jan 31, 2005 The guidelines also state that the ganciclovir intraocular implant plus VALCYTE is ... VALCYTE works by enhancing the absorption of ganciclovir through the ... Pay-Per-View - PR Newswire - HighBeam Research Human herpes virus-6 encephalitis in a paediatric bone marrow... - Oct 2, 2006 1, 3, 4 In in vitro studies, ganciclovir (GCV), foscarnet and cidofovir have ... Ganciclovir is effective for prophylaxis and treatment of human herpesvirus ... Nature.com Posttransplant Lymphoproliferative Disease - Jul 11, 2008 Low-risk patients were intravenously administered 6 to 10 mg/kg ganciclovir per day for 4 weeks, plus daily oral acyclovir 40 mg/kg for 2 years. ... Medscape High dosage of oral valaciclovir as an alternative treatment of... - Mar 18, 2005 Valganciclovir, a L-valyl ester prodrug with improved bioavailability, is hydrolysed in the gut and liver and produces ganciclovir exposure similar to iv ... Nature.com Validation of a DNAemia cutoff for preemptive therapy of cytomegalovir... - Jan 21, 2008 The gastric disease was treated with ganciclovir and resolved following a ... Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir ... Nature.com Valganciclovir is safe and effective as pre-emptive therapy for CMV … - Mar 13, 2006 The standard drug for pre-emptive therapy is intravenous ganciclovir (GCV). ... A risk-adapted approach with a short course of ganciclovir to prevent ... Nature.com Yellow-white retinal lesion in a 48-year-old woman.(Photo Quiz) - Aug 15, 2007 Intravitreal injection of ganciclovir, foscarnet, or fomivirsen (Vitravene; ... An intravitreal ganciclovir implant is also available; the device is placed ... $4.95 - American Family Physician - ECNext Cytomegalovirus Pathogenesis; Pulmonary CMV reactivation causes … - May 3, 2006 In a second experiment, a cohort of MCMV+ mice received ganciclovir (10 ... Ganciclovir treatment following cecal ligation and puncture prevented MCMV ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Crucial or cruel? - Mar 16, 2005 Case in point: Acyclovir and ganciclovir. Acyclovir is a popular and ... Ganciclovir, discovered a few years after acyclovir, looked for a time like it was ... San Diego Union - Tribune - San Diego Union Tribune Medicamentos contra enfermedades oportunistas: - Aug 4, 2005 ...èˆ Por ello, cuando se presenta un cuadro de retinitis lo ideal es dar tratamiento intravenoso con ganciclovir舡, señala. El ganciclovir es un medicamento de ... La Jornada - La Jornada (México) Cytomegalovirus retinitis in chronic lymphocytic leukaemia - Aug 18, 2006 The patient was initiated on intravenous ganciclovir (5 mg/kg every 12 h) for ... Subsequently, the patient underwent implantation of a ganciclovir implant ... Nature.com Universal prophylaxis cuts infections in solid organ transplant - Dec 29, 2005 Acyclovir at a dose in excess of 2 ga day and ganciclovir both significantly ... They also noted that prophylactic ganciclovir at a dose of 3 ga day reduced ... Medscape Ark Therapeutics Grp - Regulatory Update - Apr 22, 2008 In the following days ganciclovir is given intravenously. ... This converts the ganciclovir to a substance which specifically kills dividing cells. ... Reuters UK El tratamiento oral para la enfermedad por CMV con Valcyte podrÃa … - May 8, 2007 Valcyte es un profármaco de ganciclovir indicado para la prevención del CMV en ... Humar A. Oral valganciclovir and intravenous ganciclovir have comparable ... acceso.com Gene Research; VP22 does not significantly enhance enzyme prodrug … - Dec 8, 2005 ..."To study the capacity of VP22 to cause spreading and enhance thymidine kinase/ganciclovir cancer gene therapy, we constructed a novel triple fusion protein ... Pay-Per-View - Gene Therapy Weekly - Factiva, from Dow Jones Controlled propagation of replication-competent Sindbis viral vector... - Sep 25, 2008 Furthermore, in the presence of the prodrug ganciclovir, the hsvtk suicide gene serves as a safety mechanism to prevent uncontrolled vector propagation. ... Nature.com Oncology; Studies describe new findings in oncology research - Jul 29, 2005 According to recent research published in the journal BMC Cancer, "HSV-tk/ganciclovir (GCV) gene therapy has been extensively studied in the setting of ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Gene Research; VP22 does not significantly enhance enzyme prodrug … - Dec 5, 2005 ..."To study the capacity of VP22 to cause spreading and enhance thymidine kinase/ganciclovir cancer gene therapy, we constructed a novel triple fusion protein ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones Ohio State University, US Researchers' findings from Ohio State … - Dec 12, 2006 In a second experiment, a cohort of MCMV+ mice received ganciclovir (10 ... Ganciclovir treatment following cecal ligation and puncture prevented MCMV ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: Sirion Therapeutics Acquires US License to Develop New... - Jan 17, 2007 ..."Topical ganciclovir has been available in Europe for the treatment of ocular viral infections for over 10 years. This product has the potential to fill a ... Pay-Per-View - PR Newswire - HighBeam Research Gene Research; VP22 does not significantly enhance enzyme prodrug … - Dec 9, 2005 ..."To study the capacity of VP22 to cause spreading and enhance thymidine kinase/ganciclovir cancer gene therapy, we constructed a novel triple fusion protein ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Loislaw Federal District Court Opinions - NOVARTIS … - Sep 6, 2007 Several compounds resulted from this work, including ganciclovir (DHPG), FHBG, HBG, carba-iNDG and penciclovir. C. Prior Art Following the Burroughs ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw The effect of quantification standards used in real-time CMV PCR... - Jan 8, 2007 Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir ... Nature.com ViroPharma Initiates Phase 3 Study Of CAMVIA(TM) (maribavir) In Liver... - Jul 6, 2007 ViroPharma's Phase 3 liver transplant study will compare the efficacy, safety and tolerability of prophylactic use of CAMVIA versus oral ganciclovir when ... Medical News Today - Medical News Today (press release) Press Release: Bisphosphonates Can Wreak Havoc in the Mouth and … - May 5, 2005 Article: Oral Ganciclovir Reduces CMV Disease by 79 Percent in ... ... These reports omitted oral Cytovene(R) (ganciclovir capsules ... are battling CMV, ... Pay-Per-View - PR Newswire - HighBeam Research La infección en pacientes trasplantados, un peligro para la superviven... - Dec 14, 2006 Hasta hace pocos años, la profilaxis y el tratamiento de la infección por CMV se realizaba con ganciclovir intravenoso u oral. ... doyma.es HIV/AIDS Cancer; Research in HIV/AIDS cancer provides new insights - Feb 8, 2005 C. Casper and coauthors at the University of Washington described "the effect of ganciclovir on the clinical and virologic course of MCD in a series of ... Pay-Per-View - Science Letter - Factiva, from Dow Jones HIV/AIDS Cancer; Research in HIV/AIDS cancer provides new insights - Feb 12, 2005 C. Casper and coauthors at the University of Washington described "the effect of ganciclovir on the clinical and virologic course of MCD in a series of ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones HIV/AIDS Cancer; Research in HIV/AIDS cancer provides new insights - Feb 9, 2005 C. Casper and coauthors at the University of Washington described "the effect of ganciclovir on the clinical and virologic course of MCD in a series of ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones Efficacy of an aqueous pelargonium sidoides extract against herpesviru... - Dec 1, 2008 Acyclovir, ganciclovir and cidofo-vir are nucleoside analogues which act as DNA chain terminators, ultimately preventing elongation of viral DNA. ... Pay-Per-View - Phytomedicine: International Journal of... - HighBeam Research Drug Delivery; Sindbis viral vector enables gene-directed enzyme- … - Sep 5, 2006 Keywords: New York, New York, United States, Anti-Infectives, Drug Delivery, Enzyme Therapy, Ganciclovir, Gene Directed Enzyme Prodrug Therapy, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Cancer Gene Therapy; Delivery of monocyte chemoattractant protein-1 … - May 10, 2006 ..."Suicide gene therapy using the herpes simplex virus Thy kinase/ganciclovir (HSV-tk/GCV) system is a well-characterized tool for cancer gene therapy; ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones PHARMACY UPDATE: From sci fi to clinical reality. - Jan 15, 2005 The ganciclovir, administered a few days later, hinders the growth of new ... Ganciclovir, once activated by the thymidine kinase, destroys only rapidly ... $9.94 - Chemist & Druggist - Alacra Store Valganciclovir también es útil en otros virus distintos del citomegalo... - Jun 30, 2005 AsÃ, en 263 pacientes que recibieron profilaxis durante 100 dÃas con valganciclovir o ganciclovir oral (este último ya no es comercializado) no hubo ningún ... acceso.com Comparable incidence and severity of cytomegalovirus infections … - May 28, 2007 CMV disease would be treated with intravenous 5 mg/kg ganciclovir bid Ganciclovir ... (Val)ganciclovir was administered to an equal amount of RIC and MAC ... Nature.com EBV reactivation and post transplant lymphoproliferative disorders … - Jun 2, 2008 Ganciclovir was the treatment of choice in case of CMV reactivation/infection (2 5 mg/kg daily). In cases with high CMV load, therapy was continued for 14 ... Nature.com Vitrasert - Indications, Contre indications, Effets indésirables - Jan 10, 2006 Grossesse : les études chez l'animal ont démontré que le ganciclovir est ... Bien que chaque implant Vitrasert ne contienne que 4,5 mg de ganciclovir libéré ... Santé AZ Valganciclovir confirma sus beneficios en la prevención de la infecció... - Apr 4, 2005 Valganciclovir resulta eficaz, seguro y más cómodo que el tratamiento clásico (basado en la administración de ganciclovir endovenoso) en aquellos ... acceso.com HN70 VS registreert Valganciclovir - Jul 10, 2007 Het middel is een pro-drug van ganciclovir, een ouder middel tegen CMV. ... Ganciclovir moet per infuus gegeven (zeker tijdens de inductietherapie in de ... Hiv Vereniging Nederland People In Southeast Asia Needlessly Becoming Blind Due To A … - Dec 4, 2007 An alternative treatment using intravenous ganciclovir is cumbersome, requiring infusions twice a day for two or three weeks, and then daily infusions for ... Medical News Today - Medical News Today (press release) Viral hitch-hiker targets tumours - Sep 24, 2005 He found that the viruses were able to target tumours in mice so that when the mice were treated with ganciclovir, tumours were destroyed in 90 per cent of ... New Scientist … therapy and herpes simplex virus thymidine kinase/ganciclovir in... - Nov 16, 2008 Suicide gene therapy using herpes simplex virus thymidine kinase (HSV-TK) and ganciclovir (GCV) offers a potential treatment strategy for cancer and is ... Nature.com Un grupo selecto de expertos mundiales se reúnen en Santiago de … - Jun 24, 2005 Valcyte ha sido desarrollado para superar las limitaciones del ganciclovir oral e intravenoso, ya que con una única dosis diaria de 900 mg se obtiene una ... acceso.com Madrid acoge la IV Reunión Nacional de Infección y Trasplante - Dec 1, 2005 Además, se documenta que el tratamiento secuencial con valganciclovir (administrado después de ganciclovir intravenoso) consigue un 100% de curación ... acceso.com [U] Novartis Pharmaceuticals Corp. v. Teva Pharmaceuticals USA, Inc.,... - Sep 6, 2007 Several compounds resulted from this work, including ganciclovir (DHPG), FHBG, HBG, carbaiNDG and penciclovir. [19], C. Prior Art ... $2.95 - U.S. District Court, District of New... - VersusLaw Clinical relevance of quantitative varicella-zoster virus (VZV) DNA … - May 22, 2006 No prophylaxis with immunoglobulin, acyclovir or ganciclovir was administered. All database entries and statistical analysis were performed with SPSS ... Nature.com Oncology; Recent findings illuminate research in oncology - Feb 8, 2005 Mice transplanted with rAAV-2-EF1alpha-TK/eGFP-transduced and ganciclovir-exposed tumor cells survived >5 months while in the nontransduced group all mice ... Pay-Per-View - Virus Weekly - Factiva, from Dow Jones Gynecology; Findings in gynecology provide new insights - Feb 4, 2005 Here we show that transfection of the herpes simplex virus thymidine kinase (HSV-tk) gene, followed by incubation with up to 1 mM ganciclovir fails to ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Gynecology; Findings in gynecology provide new insights - Feb 1, 2005 Here we show that transfection of the herpes simplex virus thymidine kinase (HSV-tk) gene, followed by incubation with up to 1 mM ganciclovir fails to ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Obstetrics; Researchers' findings advance obstetrics research - Mar 29, 2005 Treatment with ganciclovir rendered these mice severely hypothyroid because ... Since ganciclovir crosses the placenta, it also destroyed the thyroid of ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Brand Names/Synonyms: Ganciclovir is also known by the following brand names and/or synonymsCytovene; Cytovene Iv; Cytovene-Iv; GA2; GCV & MSL; Ganciclovir; Ganciclovir Sodium; Gancyclovir; Hydroxyacyclovir; Valcyte; Vitrasert Drug Category: Ganciclovir is categorized under the following by the FDA: Antivirals; Nucleosides and Nucleotides (08:18.32); ATC:J05AB06; ATC:J05AB14; Dosage Forms: CAPSULE; IMPOLANT; POWDER FOR SOLUTION Absorption: Poorly absorbed orally, bioavailability is 6% to 9% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[(2-amino-6-hydroxy-purin-9-yl)methoxy]propane-1,3-diol |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |